Navigation Links
Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Date:9/30/2008

Company Targeting to Complete Enrollment of 150 patients by March 2009

SUNRISE, Fla., Sept. 30 /PRNewswire-FirstCall/ -- Bioheart, Inc., (Nasdaq: BHRT), today announced that 35 of the leading U.S. Heart Failure Centers have engaged in Bioheart's Phase II/III MARVEL(1) Trial of myogenic cells for treating advanced heart failure.

"With 35 leading heart failure centers engaged, we are making tremendous progress in patient screening and enrollment," said Dr. Warren Sherman, Principal Investigator and Director, Cardiac Cell-based Endovascular Therapies, Columbia University Medical Center, New York. "We have added nearly 45 patients into our trial in the past three months."

The MARVEL Trial, a randomized, double-blind, placebo-controlled, multi-center Phase II/III Trial involving 330 patients in North America and Europe, is the largest trial of its kind to date. Enrollment in the MARVEL Trial began in October 2007, targeting patients who fall into Class II or III heart failure. The MARVEL Trial is studying the safety and efficacy of MyoCell autologous clinical cell therapy in the treatment of congestive heart failure delivered via a MyoStar(TM) injection catheter(2), in combination with the NOGA(R) XP Cardiac Navigation System. The MyoCell injection process is a minimally invasive procedure which presents less risk and considerably less trauma to a patient than conventional (open) heart surgery.

The trial is designed for an interim look at 150 patients with six-month follow-up. Based on the statistical significance of these interim results, the Company will explore the potential to submit for early commercial approval in the United States. Bioheart is on track to complete enrollment of 150 patients by March 2009, sub
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
2. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
3. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that it ... Food and Drug Administration ("FDA") verifying that the Company ... the warning letter it received from the FDA in ... re-inspection in March 2015 by the FDA at CryoLife,s ...
(Date:4/27/2015)...   AMC Health , a leading provider of ... care that are transforming chronic care and population health ... May 2-5 at the Los Angeles ... information about how their innovative programs, solutions and services ... healthcare delivery at Booth #2116 and during their joint ...
(Date:4/27/2015)... April 27, 2015 Harwood Feffer LLP ( ... of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the ... has breached its fiduciary duties to shareholders. ... release announcing results from its first Phase 3 registration ... disclosed that in the trial, Rhopressa failed to meet ...
Breaking Medicine Technology:CryoLife Announces Resolution of FDA Warning Letter 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2
... NORTH WALES, Pa., Feb. 16, 2011 AirPal, a ... received notification of allowance from the U.S. Patent Office ... position patients for situations such as difficult airway management, ... The company, founded in 1982, now holds more than ...
... and Willkie Farr & Gallagher will host an anti-bribery ... trends on French companies operating internationally. The seminar will ... of Willkie Farr & Gallagher. Please visit www.traceinternational.org ... event or contact king@traceinternational.org French ...
Cached Medicine Technology:AirPal Receives Patent for Inflatable Patient Positioning Systems 2TRACE and Willkie Farr Announce Anti-Bribery Seminar in Paris 2
(Date:4/27/2015)... 27, 2015 "Understanding Mental Disorders: Your ... 1 by American Psychiatric Publishing, a division of the ... 1pm at the National Press Club in Washington, D.C.. ... moderated by APA President Paul Summergrad, MD. Guest speakers ... the foreword to the book; Paul Gionfriddo, President and ...
(Date:4/27/2015)... Md. (PRWEB) April 27, 2015 On May ... ones will ask their social media friends around the world ... dismissed as asthma. , May 5 is World Pulmonary ... (PHA), a leader in the global PH community, will take ... or high blood pressure of the lungs. PH is an ...
(Date:4/27/2015)... According to a recent report from NIDCR ... back pain, TMJ disorders are the second most ... In addition, the report revealed that TMJ disorders affect ... an estimated 4 billion dollars annually. , These estimates ... unrelated symptoms such as headaches, neck pain, tenderness of ...
(Date:4/27/2015)... As ISO 27001 has quickly become the ... all sizes and in all industries, Pivot Point Security ... ISO 27001 certification. The information security audit firm has ... ISO 27001 certification. Pivot Point's commitment to ISO 27001 ... of Lead Implementers and Auditors the company employs (now ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Guided by ... field of patient experience and its collaboration with organizations ... The Beryl Institute identifies eight essential actions ... The Beryl Institute believes organizations and systems committed to ... Identify and support accountable leadership with committed time ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 3Health News:Dentist in Graham NC Reveals that a Jaw Disorder May Be the Cause of Chronic Headaches and Back Pain 2Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2
... breakdown of retinoic acid, derived from vitamin A, is ... models of human prostate cancer, say investigators from the ... of the agent VN/14-1 resulted in up to a ... with human prostate cancer cells, reported Aakanksha Khandelwal, Ph.D., ...
... Study Supported Efficacy, Safety and Tolerability of ... 13-17 with Schizophrenia -, TOKYO and PRINCETON, ... Bristol-Myers Squibb Company (NYSE: BMY ) announced ... approved the supplemental New,Drug Application for the atypical ...
... increase 21% over the ... FARMINGTON, Conn., Nov. 6 Darwin Professional,Underwriters, Inc. ("Darwin," the ... for the third quarter ended September 30,2007. Highlights include: -- ... Third quarter gross premiums written are 5.9% ...
... ARLINGTON, Va., Nov. 6 In ... Network,s, (http://www.HealthCentral.com ) MyDiabetesCentral.com has launched ... of those with diabetes and provides,important ... this condition. The,special section, which can ...
... 6 QED International Associates Inc.,administrator for the ... portfolios, today announced that effective at the,opening of ... Ltd.,(Nasdaq: GIVN ) will replace Dade Behring ... Diagnostics Index, and Inverness Medical Innovations,(Amex: IMA ...
... Toronto, ON (November 6, 2007) Canadian researchers expect to ... network of hundreds of thousands of people who volunteer their ... complex problems. , The research team, led by Dr. ... at Princess Margaret Hospital and University Health Network, are the ...
Cached Medicine News:Health News:Drug slows prostate tumor growth by keeping vitamin A active 2Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 2Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 3Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 4Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 5Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 6Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 7Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 8Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 7Health News:The HealthCentral Network's MyDiabetesCentral.com Promotes Awareness of Diabetes 2Health News:The HealthCentral Network's MyDiabetesCentral.com Promotes Awareness of Diabetes 3Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes 2Health News:IBM world community grid squeezes decades of cancer research into 2 years 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: